Financials
Income statement
Fiscal date | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 |
---|---|---|---|---|
Total reported revenue | 18.6B | 17.5B | 15.4B | 12.9B |
Cost of revenue | 13.3B | 12.7B | 11.2B | 9.2B |
Gross profit | 5.3B | 4.7B | 4.2B | 3.7B |
Operating expense | ||||
Research & development | 538.5M | 467.1M | 397.4M | 344.0M |
Selling general and admin | 1.2B | 1.1B | 912.8M | 856.7M |
Other operating expenses | — | — | — | — |
Operating income | 3.5B | 3.2B | 2.9B | 2.5B |
Non operating interest income | ||||
Income | 45.7M | 38.8M | 32.4M | 26.7M |
Expense | 118.8M | 121.2M | 117.6M | 101.2M |
Other income expense | — | — | — | — |
Pretax income | 3.4B | 3.2B | 3.0B | 2.6B |
Tax provision | 726.4M | 659.3M | 541.7M | 636.5M |
Net income | 2.6B | 2.5B | 2.4B | 2.0B |
Basic EPS | — | 7.3 | 7.1 | 5.8 |
Diluted EPS | — | 7.3 | 7.0 | 5.7 |
Basic average shares | — | 344.7M | 344.0M | 343.6M |
Diluted average shares | — | 347.1M | 347.5M | 347.6M |
EBITDA | 4.1B | 3.8B | 3.5B | 3.1B |
Net income from continuing op. | 3.4B | 3.2B | 3.0B | 2.6B |
Minority interests | 4.3M | 1.6M | 2.3M | 1.2M |
Preferred stock dividends | 0 | 0 | 0 | 0 |